07.10.2016
- German drugmaker Boehringer Ingelheim is selling the pet vaccines portfolio of its US subsidiary Vetmedica to Eli Lilly’s animal health subsidiary Elanco for $885 million to allay...
29.06.2016
- Following six months of negotiations, French drugmaker Sanofi and German pharmaceutical company Boehringer Ingelheim have agreed an asset swap that sees Sanofi exchanging its...
14.04.2016
- Bayer is still committed to expanding its animal health business, but would consider selling it if suitable takeover targets remain elusive, newly named CEO Werner Baumann has told...
04.04.2016
- Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...
23.12.2015
- Bayer is likely to seek a major life sciences M&A deal in the next few years, banking sources have told the news agency Reuters. The German group’s absence from a recent wave of...
16.12.2015
- French drugmaker Sanofi and German pharmaceutical company Boehringer Ingelheim have begun exclusive negotiations toward a swap of Sanofi’s subsidiary Merial, a manufacturer of...
01.06.2015
- An initial public offering of the Bayer MaterialScience (BMS) is the most likely option for the Bayer group to separate out the plastics subgroup as it hasn't received any...
19.02.2015
- As had been widely speculated, Olivier Brandicourt, currently CEO of Bayer HealthCare, will leave the company at the end of March and become new CEO of French pharmaceutical...
